Many pharmas or biotechs may not know the opportunities available from working with the U.S. Army on license agreements or Collaborative Research and Development Agreements (CRADAs). Here’s what to know about the Medical Technology Transfer (MTT) office.
Traditionally, firms seek out leadership candidates who are strong "cultural fits." In the case of Big Pharma hiring experts in gene and cell therapies, however, they should be looking for "misfits" if you will.
The story of the business challenges faced by Diasome Pharmaceuticals as it develops its insulin-enhancing delivery technology, which seeks to correct a long-known deficiency in subcutaneous injection of insulin.
Real-world evidence is playing an increasingly important role throughout the drug development lifecycle—as outlined in Deloitte's latest survey on the life sciences industry's RWE capabilities— and companies are really beginning to take notice.